US: JAMA Warns Against Myocarditis After mRNA-Based COVID-19 Vaccination
The rates of myocarditis cases were highest after the second vaccination dose in adolescent males aged 12 to 15 years. Males comprised 82% of the myocarditis cases for whom sex was reported. The JAMA researchers warned that “this risk should be considered in the context of the benefits of COVID-19 vaccination.”